Multicomponent therapeutics for networked systems
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Therapeutic regimens that comprise more than one active ingredient are commonly used in clinical medicine. Despite this, most drug discovery efforts search for drugs that are composed of a single chemical entity. A focus in the early drug discovery process on identifying and optimizing the activity of combinations of molecules can result in the identification of more effective drug regimens. A systems perspective facilitates an understanding of the mechanism of action of such drug combinations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“combinations of chemical agents (or manipulations such as those of transcription factors that affect multiple steps in a pathway [1906] or modulation of multiple gene products [2311], or both [2312,2313]) will be far more efficacious, for instance in modulating iron-catalysed oxidative stress and its sequelae, than will be the use of 'magic bullet' single agents.”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1705]
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178 · cited 1×
“There have been attempts to systematize a set of principles that can account for combination drugs that exist toda”
BackgroundLessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Systems biology: a brief overview
Kitano, H. (2002) · Science · doi:10.1126/science.1069492 · Cited by 4,265 · cited 1×
“Systems biology is the large-scale study of the functional and physical relationships between the molecules that make up lif”
BackgroundBlume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
Transcriptional Regulatory Networks in Saccharomyces cerevisiae
Lee, T. I., Rinaldi, N. J., Robert, F., Odom, D. T., Bar-Joseph, Z., Gerber, G. K., Hannett, N. M., Harbison, C. T., Thompson, C. M., Simon, I., et al. (2002) · Science · doi:10.1126/science.1075090 · Cited by 2,956
THE TOXICITY OF POISONS APPLIED JOINTLY1
BLISS, C. I. (1939) · Annals of Applied Biology · doi:10.1111/j.1744-7348.1939.tb06990.x · Cited by 2,419 · cited 1×
“Numerous researchers have attempted to provide an unambiguous framework for the calculation of additive effects between compounds; these approaches are reviewed comprehensively elsewher”
BackgroundSystematic Genetic Analysis with Ordered Arrays of Yeast Deletion Mutants
Tong, A. H. Y., Evangelista, M., Parsons, A. B., Xu, H., Bader, G. D., Pagé, N., Robinson, M., Raghibizadeh, S., Hogue, C. W. V., Bussey, H., et al. (2001) · Science · doi:10.1126/science.1065810 · Cited by 2,138
A N EW A PPROACH TO D ECODING L IFE : Systems Biology
Ideker, T., Galitski, T., & Hood, L. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.343 · Cited by 1,664 · cited 1×
“Systems biology is the large-scale study of the functional and physical relationships between the molecules that make up lif”
BackgroundDolma, S., Lessnick, S. L., Hahn, W. C., & Stockwell, B. R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00050-3 · Cited by 1,446
Self-citationThe search for synergy: a critical review from a response surface perspective.
Greco, W. R., Bravo, G., & Parsons, J. C. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06847-4 · Cited by 1,434
On the allelic spectrum of human disease
Reich, D. E., & Lander, E. S. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02410-6 · Cited by 1,185 · cited 1×
“Many diseases with a high incidence in the population, such as diabetes, heart disease, cancer, arthritis, asthma and depression, have a multifactorial basis that involves both genetic and environmental risk factor”
BackgroundSchoeberl, B., Eichler-Jonsson, C., Gilles, E. D., & Müller, G. (2002) · Nature Biotechnology · doi:10.1038/nbt0402-370 · Cited by 950 · cited 1×
“A growing number of scientists in drug discovery are embracing efforts to understand biology and disease through the in silico modelling of cellular system”
Background(1953) · PubMed · Cited by 942
Principles for the buffering of genetic variation
Hartman, J. L., Garvik, B., & Hartwell, L. (2001) · Science · doi:10.1126/science.1056072 · Cited by 808
Principles for the Buffering of Genetic Variation
Hartman IV, J. L. (2001) · Science · doi:10.1126/science.291.5506.1001 · Cited by 808 · cited 1×
“Such examples of conditional activity are the pharmacological equivalents of synthetic lethal genetic effects that are found in model organisms such as Saccharomyces cerevisiae”
BackgroundStermitz, F. R., Lorenz, P., Tawara, J. N., Zenewicz, L. A., & Lewis, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.030540597 · Cited by 761
Cancer principles and practice of oncology
Kerin, M. J. (1997) · Surgical Oncology · doi:10.1016/s0960-7404(97)90012-8 · Cited by 739
Identifying regulatory networks by combinatorial analysis of promoter elements
Pilpel, Y., Sudarsanam, P., & Church, G. M. (2001) · Nature Genetics · doi:10.1038/ng724 · Cited by 652 · cited 1×
“Many signalling networks in mammalian cells are also likely to be wired with redundant pathways, such that optimal therapeutic interventions can be achieved through perturbing several different points of the networ”
BackgroundPotential Mechanism for Sustained Antiretroviral Efficacy of AZT-3TC Combination Therapy
Larder, B. A., Kemp, S. D., & Harrigan, P. R. (1995) · Science · doi:10.1126/science.7542804 · Cited by 623
Systematic discovery of multicomponent therapeutics
Borisy, A. A., Elliott, P. J., Hurst, N. W., Lee, M. S., Lehár, J., Price, E. R., Serbedzija, G., Zimmermann, G. R., Foley, M. A., Stockwell, B. R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1337088100 · Cited by 620
Self-citationAnalysis of combined drug effects: a new look at a very old problem
Chou, T.-C., & Talalay, P. (1983) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(83)90490-x · Cited by 619 · cited 1×
“There have been attempts to systematize a set of principles that can account for combination drugs that exist toda”
BackgroundHumbert, S., Bryson, E. A., Cordelières, F. P., Connors, N. C., Datta, S. R., Finkbeiner, S., Greenberg, M. E., & Saudou, F. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00188-0 · Cited by 509
Role of interferons and other cytokines in the regulation of the immune response
Belardelli, F. (1995) · APMIS · doi:10.1111/j.1699-0463.1995.tb01092.x · Cited by 471
Chemical genetics: ligand-based discovery of gene function
Stockwell, B. R. (2000) · Nature Reviews Genetics · doi:10.1038/35038557 · Cited by 421 · cited 1×
“In recent years, there has been a great improvement in the availability and creation of disease-relevant cell-based assays for phenotypic screenin”
BackgroundSelf-citationTraditional Chinese medicine an approach to scientific proof and clinical validation
Yuan, R. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00039-5 · Cited by 329
Kavuru, M., Melamed, J., Gross, G., LaForce, C., House, K., Prillaman, B., Baitinger, L., Woodring, A., & Shah, T. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.105711 · Cited by 237 · cited 1×
“In one clinical trial involving 356 patients, Advair significantly improved baseline 1-second forced expiratory volume (FEV 1 ) by 25%, which is greater than that achieved with either of the individual components fluticasone (15%) or salmeterol (5%), or a placebo (1%”
BackgroundSynthetic enhancement in gene interaction: a genetic tool come of age
Guarente, L. (1993) · Trends in Genetics · doi:10.1016/0168-9525(93)90042-g · Cited by 236 · cited 1×
“Such examples of conditional activity are the pharmacological equivalents of synthetic lethal genetic effects that are found in model organisms such as Saccharomyces cerevisiae”
BackgroundPANCREATITIS INDUCED BY 5-AMINOSALICYLIC ACID
Deprez, P., Descamps, C., & Fiasse, R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90620-x · Cited by 230
Die quantitativen Probleme der Pharmakologie
Loewe, S. (1928) · Ergebnisse der Physiologie · doi:10.1007/bf02322290 · Cited by 229 · cited 1×
“, and, in 1928, Loewe and others studied the interaction between other defined drug combination”
BackgroundNew components of the honey bee ( Apis mellifera L.) queen retinue pheromone
Keeling, C. I., Slessor, K. N., Higo, H. A., & Winston, M. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0836984100 · Cited by 223
Multiple Novel Inhibitors of the NorA Multidrug Transporter of Staphylococcus aureus
Markham, P. N., Westhaus, E., Klyachko, K., Johnson, M. E., & Neyfakh, A. A. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2404 · Cited by 218 · cited 1×
“For example, cell-based assays can be used to identify antibacteria”
MethodToxicology of simple and complex mixtures
Groten, J. P., Feron, V. J., & Sühnel, J. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01720-x · Cited by 185 · cited 1×
“Numerous researchers have attempted to provide an unambiguous framework for the calculation of additive effects between compounds; these approaches are reviewed comprehensively elsewher”
BackgroundLoktionov, A. S. (2003) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(03)00032-9 · Cited by 176 · cited 1×
“Many diseases with a high incidence in the population, such as diabetes, heart disease, cancer, arthritis, asthma and depression, have a multifactorial basis that involves both genetic and environmental risk factor”
BackgroundBays, H. E., Dujovne, C. A., McGovern, M. E., White, T. E., Kashyap, M. L., Hutcheson, A. G., & Crouse, J. R. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00007-9 · Cited by 154
Brent, R. (2000) · Cell · doi:10.1016/s0092-8674(00)81693-1 · Cited by 148
Marschall, M., Freitag, M., Weiler, S., Sorg, G., & Stamminger, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1588-1597.2000 · Cited by 143
Frontiers in chemical genetics
Stockwell, B. R. (2000) · Trends in biotechnology · doi:10.1016/s0167-7799(00)01499-2 · Cited by 96 · cited 1×
“In recent years, there has been a great improvement in the availability and creation of disease-relevant cell-based assays for phenotypic screenin”
BackgroundSelf-citationBiological mechanism profiling using an annotated compound library
Root, D. E., Flaherty, S. P., Kelley, B. P., & Stockwell, B. R. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.08.009 · Cited by 95
Self-citationCuratolo, M., & Sveticic, G. (2002) · Best practice & research. Clinical anaesthesiology · doi:10.1053/bean.2002.0254 · Cited by 91
Advair: Combination treatment with fluticasone propionate/salmeterol in the treatment of asthma
Nelson, H. S. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.112939 · Cited by 88 · cited 1×
“The combination therefore provides greater benefit to the patient than either agent alon”
BackgroundFunctional genomics as applied to mapping transcription regulatory networks
Banerjee, N., & Zhang, M. Q. (2002) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(02)00322-3 · Cited by 75 · cited 1×
“Many signalling networks in mammalian cells are also likely to be wired with redundant pathways, such that optimal therapeutic interventions can be achieved through perturbing several different points of the networ”
BackgroundAn overview of the FDA publication Approved Drug Products with Therapeutic Equivalence Evaluations
Knoben, J. E., Scott, G. R., & Tonelli, R. J. (1990) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/47.12.2696 · Cited by 50
A New Integrated Program for Natural Product Development and the Value of an Ethnomedical Approach
Schuster, B. G. (2001) · The Journal of Alternative and Complementary Medicine · doi:10.1089/107555301753393823 · Cited by 47 · cited 1×
“Many of the natural product extracts that have been tested have yielded activities that later disappeared when the extracts were fractionated into individual chemical component”
BackgroundGupta, E. K., & Ito, M. K. (2002) · Heart Disease · doi:10.1097/00132580-200203000-00010 · Cited by 47 · cited 1×
“Advicor was developed on the basis of clinical observations that indicated the benefits of taking both niacin and a statin, which inhibits 5-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductas”
BackgroundNakayama, T., Honda, K., Ômura, H., & Hayashi, N. (2003) · Journal of Chemical Ecology · doi:10.1023/a:1024274814402 · Cited by 46
Target Analysis: A Priori Assessment of Druggability
Hopkins, A. L., & Groom, C. R. (2003) · Springer eBooks · doi:10.1007/978-3-662-05314-0_2 · Cited by 45
5. An Experimental Research on the Antagonism between the Actions of Physostigma and Atropia
Fraser, T. R. (1872) · Proceedings of the Royal Society of Edinburgh · doi:10.1017/s0370164600042565 · Cited by 42
Chemical Genetic Screening Approaches to Neurobiology
Stockwell, B. R. (2002) · Neuron · doi:10.1016/s0896-6273(02)01056-5 · Cited by 34
Self-citationNatural product source material use in the pharmaceutical industry: the Glaxo experience
Turner, D. M. (1996) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(95)01348-2 · Cited by 33 · cited 1×
“Many of the natural product extracts that have been tested have yielded activities that later disappeared when the extracts were fractionated into individual chemical component”
BackgroundRole of Dendritic Cell-Derived Cytokines in Immune Regulation
Wan, Y., & Bramson, J. L. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013397627 · Cited by 29
Amoxicillin-potassium clavulanate, a β-lactamase-resistant antibiotic combination
Stein, G. E., & Gurwith, M. (1984) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/41.12.2685 · Cited by 26
Maga, G., & Spadari, S. (2002) · Current Drug Metabolism · doi:10.2174/1389200023337982 · Cited by 21
Arteaga, C. L. (2003) · PubMed · Cited by 20
Danis, M., & Bricaire, F. (2003) · Fundamental and Clinical Pharmacology · doi:10.1046/j.1472-8206.2003.00165.x · Cited by 19
Genomics and medicine: an anticipation.
Kaplan, J., & Junien, C. (2000) · Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie · doi:10.1016/s0764-4469(00)01252-x · Cited by 17
Eliminating membrane depolarization caused by the Alzheimer peptide Aβ(1–42, aggr.)
Blanchard, B. J., Stockwell, B. R., & Ingram, V. M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00290-5 · Cited by 16
Self-citationTwo- versus three-drug combinations in the chemotherapy of advanced non-small-cell lung cancer
Pirker, R. (2002) · Lung Cancer · doi:10.1016/s0169-5002(02)00270-2 · Cited by 13
Jc, K. (2000) · Comptes Rendus Biologies · Cited by 13
New drugs and combinations for malignant glioma.
Stupp, R., & R��egg, C. (2003) · PubMed · Cited by 12
Jd, H., Burris, H. A., & Greco, F. A. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90078-8 · Cited by 12
Foungbé, S., Kouassi, G. M., Kablan, J., & Marcy, R. (1991) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(91)90080-w · Cited by 12 · cited 1×
“Many of the natural product extracts that have been tested have yielded activities that later disappeared when the extracts were fractionated into individual chemical component”
BackgroundXXI.—An Experimental Research on the Antagonism between the Actions of Physostigma and Atropia
Fraser, T. R. (1871) · Transactions of the Royal Society of Edinburgh · doi:10.1017/s008045680001139x · Cited by 11
Mondimore, F. M., Fuller, G. A., & DePaulo, J. R. (2003) · PubMed · Cited by 9
The development of combination drugs for atherosclerosis
Black, D. M. (2003) · Current Atherosclerosis Reports · doi:10.1007/s11883-003-0065-3 · Cited by 7 · cited 1×
“This combination provides a greater decrease in low-density lipoprotein (LDL) concentration and a greater increase in high-density lipoprotein (HDL) concentration, both of which are desired and beneficial effect”
BackgroundPromising New Drugs and Combinations…Fulfilling Our Pledge
Chabner, B. A. (1999) · The Oncologist · doi:10.1634/theoncologist.4-4-0iii · Cited by 2
Nelson, H. S. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.115040 · Cited by 2
AZT plus 3TC produces best results to date.
Grodeck, B. (1995) · PubMed · Cited by 1
Research works printed but not linked: 2
- Ehrlich, P. Chemotherapeutics: scientific principles, methods and results. Lancet 2, 445–451 (1913).
- Albert, A. Selective Toxicity (Methuen & Co., London, 1968).
Cited by
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
How antibiotics kill bacteria: from targets to networks
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2333 · Cited by 2,258
Curcumin as “Curecumin”: From kitchen to clinic
Goel, A., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.016 · Cited by 2,214
“[204] Keith CT, Borisy AA, Stockwell BR.”
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
Traditional Chinese medicine network pharmacology: theory, methodology and application
LI, S., & ZHANG, B. (2013) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(13)60037-0 · Cited by 1,329
Metadata
- Authors
- Keith, C. T., Borisy, A. A., & Stockwell, B. R.
- Affiliations
- Columbia University (US)
- Corresponding author
- Keith, Curtis T.
- Borisy, Alexis A.
- Stockwell, Brent R.
- ORCID
- Stockwell, Brent R.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2005-01
- Volume
- 4
- Issue
- 1
- Pages
- 71-78
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1592483428
- Cited by
- 769
- References
- 67
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 30 · 2023: 33 · 2022: 44 · 2021: 36 · 2020: 34 · 2019: 36 · 2018: 42 · 2017: 29 · 2016: 43 · 2015: 51 · 2014: 55 · 2013: 49 · 2012: 47
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Burroughs Wellcome Fund
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene Regulatory Network Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Keywords
- combination therapy, systems biology, mechanism of action, drug discovery
- MeSH terms
- Clinical Trials as Topic, Drug Synergism, Drug Therapy, Combination, Humans, Terminology as Topic, Drug Design
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.